No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Reduced intensity chemotherapy improves quality of life without reducing survival in frail or elderly patients with gastroesophageal cancer

byTeddy Guo

September 4, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Anakinra was not superior to placebo in treating palmoplantar pustulosis (APRICOT)

RelatedReports

StudyGraphics

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

March 24, 2025

StudyGraphics

#VisualAbstract: First-Line Sugemalimab Plus Chemotherapy Provides Survival Benefit in Advanced Gastric Cancer

March 7, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Jamie Foxx Back in Action, Paracetamol for Pain, FDA Against Addictive Vape Flavours, and Coffee and Tea, Beyond Caffeine:

January 7, 2025

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Chronic Disease

Sintilimab improves survival in advanced non-metastatic nasopharyngeal carcinoma

July 30, 2024

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Substantial prevalence of transthyretin amyloid cardiomyopathy present in patients with heart failure with preserved ejection fraction

Galcanezumab reduces the frequency of episodic cluster headaches

More omega-3 and less omega-6 fatty acid consumption associated with reduced migraine frequency and severity

$#VisualAbstract Obinutuzumab-atezolizumab-lenalidomide is effective and tolerable in patients with relapsed/refractory follicular lymphoma$

#VisualAbstract Obinutuzumab-atezolizumab-lenalidomide is effective and tolerable in patients with relapsed/refractory follicular lymphoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports